Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
The Healthcare ETF Showdown: Broad Global Health or Targeted Pharma Power?
Deciding between Invesco Pharmaceuticals ETF (PJP +0.25%) and iShares Global Healthcare ETF (IXJ +0.06%) involves choosing between a focused bet on U.S. drugmakers and broad exposure to global healthcare sectors. While both Invesco Pharmaceuticals…
Bristol Myers Squibb vs. Vertex: Which Pharma Stock Is a Better Buy for 2027?
Investors choosing between Bristol Myers Squibb (BMY -1.57%) and Vertex Pharmaceuticals (VRTX +0.85%) must decide between a steady value play and a high-growth innovator as they look toward 2027. Bristol Myers Squibb operates as a diversified drug…
Nuvectis Pharma (NASDAQ:NVCT) Cut to 'Sell' at Wall Street Zen
Nuvectis Pharma (NASDAQ:NVCT - Get Free Report) was downgraded by Wall Street Zen from a 'hold' rating to a 'sell' rating in a research report issued on Saturday, Wall Street Zen reports. A number of other research analysts also recently weighed in…
Royalty Pharma PLC (RPRX) - What Are Brokerages Thinking About This Stock?
Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) has been given an average recommendation of 'Buy' by the eight research firms that are presently covering the firm, MarketBeat reports. Eight investment analysts have rated the stock with a buy…
Nuvectis Pharma (NASDAQ:NVCT) Rating Lowered to Strong Sell at Zacks Research
Nuvectis Pharma (NASDAQ:NVCT - Get Free Report) was downgraded by equities research analysts at Zacks Research from a 'hold' rating to a 'strong sell' rating in a research report issued on Thursday. Several other research analysts also recently…
Urogen Pharma $URGN Stock: Privium Fund Management B.V. Decreases Position
Privium Fund Management B.V. decreased its position in Urogen Pharma (NASDAQ:URGN - Free Report) by 48.6% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 107,915 shares of the company's stock after…
47,034 Royalty Pharma PLC $RPRX Shares Acquired by Calamos Advisors LLC
Calamos Advisors LLC raised its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 8.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned…
Privium Fund Management B.V. Sells 250,999 Shares of BridgeBio Pharma, Inc. $BBIO
Privium Fund Management B.V. lessened its stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 73.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 89,151 shares…
Avalyn Pharma (NASDAQ:AVLN) Share Price Crosses Above Fifty Day Moving Average - Time to Sell?
Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report) shares crossed above its fifty day moving average during trading on Friday. The stock has a fifty day moving average of $29.11 and traded as high as $29.18. Avalyn Pharma shares last traded at…
Nuvectis Pharma (NASDAQ:NVCT) Stock Price Breaks Above Fifty Day Moving Average - Here's What Happened
Nuvectis Pharma, Inc. (NASDAQ:NVCT - Get Free Report) shares crossed above its 50-day moving average during trading on Friday. The stock has a 50-day moving average of $20.89 and traded as high as $21.05. Nuvectis Pharma shares last traded at…
Samvat 2082: Indian Markets Rebound, End Weakest Year in 15 on a High Note
Despite a challenging year marked by geopolitical tensions and foreign selling, Indian equity markets, including the Sensex and Nifty 50, staged a remarkable late recovery to end Samvat 2082 on a strong note, marking their weakest Samvat in 15…
Ginkgo Bioworks: 3 Key Takeaways for Long-Term Investors
On its third-quarter 2026 earnings call, held on Nov. 5, 2026, Ginkgo Bioworks (DNA +13.35%) announced a strategic transition toward commercializing autonomous laboratory hardware and cloud data services. For long-term investors, this operational…
Wall Street Is Ignoring Bristol Myers Squibb's Cash Machine -- and That's an Opportunity for Income Investors
Bristol Myers Squibb (BMY -1.57%) traces its history back to the mid-1800s. It is a proven survivor in the highly competitive and innovation-driven pharmaceutical sector. That can't save the company from the normal dynamics of the drug industry, as…
RFK Jr. Stands 'FIRMLY BEHIND' Trump as Democrats Demand He Resign
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. has made his position clear: he stands 'firmly behind' President Donald Trump and the 'historic reforms' the administration is advancing, according to a report from Breitbart. The…
Kohl's: Retailer Downgraded To Neutral Ahead Of Q3 Results, Awaiting Improved Earnings
Albert Anthony is the pen name of a business author on Amazon and a contributing analyst to investing platforms like Seeking Alpha since 2023, where he has over + 2,000 followers and has covered hundreds of stocks in multiple sectors including…
Receive a Daily briefing on Pharma Industry News
Get Started